The ageing population and increased demand for healthcare products and services across the globe are creating great opportunities for businesses in the health and social care, medical devices, life sciences, bioscience and pharmaceutical markets. At the same time the delivery of global healthcare is changing fast and creating significant opportunities for private providers.

At Clearwater International we have the knowledge, experience, track record and reach to help companies exploit these growing global opportunities. Given these dynamics it’s a market which remains a rich source of M&A deal flow and corporate activity as private providers take advantage of outsourcing opportunities and investors seek to consolidate market positions. Our sector team works closely with innovative companies who are at the forefront of the healthcare revolution, advising businesses on their strategies for dealing with governments seeking to drive efficiencies and improve patient experiences.


Sector Comments

Healthcare sector comment: A look back at 2017

2017 saw 2011 deals complete, with Q2 showing the strongest performance with 29.4%, followed by Q1 with 27.6%, Q3 with 24.1% and Q4 with 18.9%. The majority of these deals were in the health and social care sub-sector with 56.3%, … Find out more…

Healthcare sector comment: Wound care, hygiene and infection control

Players in the healthcare market are focused on minimising health costs by reducing hospital stays and by using cost effective products to support this strategy. Over the last 12 months we have seen a continued interest in wound care, hygiene … Find out more…

Healthcare sector comment: Dental services

The dental market in Western Europe remains highly fragmented and presents an investment opportunity to both financial investors and strategic buyers. The consolidation provides both operational and procurement efficiencies which drives further M&A activity. We’ve seen a significant amount of … Find out more…